↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Araz M) srt2:(2017)"

Search: WFRF:(Araz M) > (2017)

Result 1-2 of 2

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Ridker, PM, et al. (author) Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients 2017 In: The New England journal of medicine. - 1533-4406 .- 0028-4793. ; 376:16, s. 1527-1539 Journal article (peer-reviewed)
2.	Katsarou, Anastasia, et al. (author) Type 1 diabetes mellitus 2017 In: Nature Reviews Disease Primers. - : Springer Science and Business Media LLC. - 2056-676X. ; 3 Journal article (peer-reviewed)abstract Type 1 diabetes mellitus (T1DM), also known as autoimmune diabetes, is a chronic disease characterized by insulin deficiency due to pancreatic beta-cell loss and leads to hyperglycaemia. Although the age of symptomatic onset is usually during childhood or adolescence, symptoms can sometimes develop much later. Although the aetiology of T1DM is not completely understood, the pathogenesis of the disease is thought to involve T cell-mediated destruction of beta-cells. Islet-targeting autoantibodies that target insulin, 65 kDa glutamic acid decarboxylase, insulinoma-associated protein 2 and zinc transporter 8 - all of which are proteins associated with secretory granules in beta-cells -are biomarkers of T1DM-associated autoimmunity that are found months to years before symptom onset, and can be used to identify and study individuals who are at risk of developing T1DM. The type of autoantibody that appears first depends on the environmental trigger and on genetic factors. The pathogenesis of T1DM can be divided into three stages depending on the absence or presence of hyperglycaemia and hyperglycaemia-associated symptoms (such as polyuria and thirst). A cure is not available, and patients depend on lifelong insulin injections; novel approaches to insulin treatment, such as insulin pumps, continuous glucose monitoring and hybrid closed-loop systems, are in development. Although intensive glycaemic control has reduced the incidence of microvascular and macrovascular complications, the majority of patients with T1DM are still developing these complications. Major research efforts are needed to achieve early diagnosis, prevent beta-cell loss and develop better treatment options to improve the quality of life and prognosis of those affected.

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-2 of 2

Refine your search

Type of publication: journal article (2)

Type of content: peer-reviewed (2)

Author/Editor: Jackson, B. (1); Li, S. (1); Li, Y. (1); Price, D. (1); Schmidt, E. (1); Solar, M. (1); show more...; Zhang, L. (1); Zhang, X. (1); Zhu, Y. (1); Zhao, Y. (1); Zhou, C. (1); Zhou, Y. (1); Ahmad, A. (1); Li, J. (1); Miller, M. (1); Albert, M (1); Zhang, Y. (1); Ma, Y. (1); Sharma, S. (1); Martin, S. (1); Johnson, M. (1); Mukherjee, A. (1); Li, D. (1); Wang, D. (1); Wang, Y. (1); Yoon, J. (1); Nguyen, T. (1); Kim, K. (1); Weiss, R. (1); Smith, P. (1); Lee, S (1); Williams, M (1); Klein, G (1); Brenner, H (1); Chang, AR (1); Cohen, AJ (1); Saxena, S (1); Sharma, R (1); Yang, P. (1); Yang, X. (1); Chen, J. (1); He, Y. (1); Demin, A (1); Konstantinov, V. (1); Szilagyi, I (1); van Royen, N (1); Katz, A. (1); Vincent, S. (1); Jiang, J. (1); Schmidt, U. (1); show less...

University: Lund University (2); University of Gothenburg (1); Karolinska Institutet (1)

Language: English (2)

Research subject (UKÄ/SCB): Medical and Health Sciences (2)

Year: 2017 (2)Undo refine

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view